HOUSE DOCKET, NO. 3083        FILED ON: 1/20/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 3242

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Kate Hogan

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to review the quality and patient safety of dispensing certain cancer and chronic disease related drugs.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Kate Hogan

3rd Middlesex

1/20/2017

Chris Walsh

6th Middlesex

1/20/2017

Steven Ultrino

33rd Middlesex

2/3/2017

Thomas M. Stanley

9th Middlesex

2/3/2017

Jennifer E. Benson

37th Middlesex

 

Smitty Pignatelli

4th Berkshire

 

Jason M. Lewis

Fifth Middlesex

 

Bradford R. Hill

4th Essex

 

Colleen M. Garry

36th Middlesex

 

Keiko M. Orrall

12th Bristol

 

Jennifer L. Flanagan

Worcester and Middlesex

 

Sean Garballey

23rd Middlesex

 

Danielle W. Gregoire

4th Middlesex

 

Bruce E. Tarr

First Essex and Middlesex

 

Daniel M. Donahue

16th Worcester

 

Mary S. Keefe

15th Worcester

 

James J. O'Day

14th Worcester

 


HOUSE DOCKET, NO. 3083        FILED ON: 1/20/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 3242

By Ms. Hogan of Stow, a petition (accompanied by bill, House, No. 3242) of Kate Hogan and others for legislation to analyze health insurance payer practices that require certain categories of drugs.  Public Health.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninetieth General Court
(2017-2018)

_______________

 

An Act to review the quality and patient safety of dispensing certain cancer and chronic disease related drugs.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. The health policy commission, in consultation with the department of public health and the division of insurance, shall study and analyze health insurance payer practices that require certain categories of drugs, including those that are administered by injection or infusion, to be dispensed by a third-party specialty pharmacy directly to a patient or to a health care provider with the designation that such drugs be used for a specific patient and not for the general use of the provider. The commission shall file a report of its findings, including recommended legislation, with the senate and house committees on ways and means, the joint committee on health care financing and the joint committee on public health not later than January 1, 2018.